Passa al contenuto
Merck
Tutte le immagini(2)

Documenti

NXF-00

Millipore

Natrix® Assorbitore a membrana Q

Sinonimo/i:

Natrix® Q Membrane Adsorber

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(2)

About This Item

Codice UNSPSC:
41115711

Materiali

media (Macroporous Polymer)
polypropylene device

Descrizione

Natrix® Q Micro

Nome Commerciale

Natrix®

Confezionamento

pack of 10 × 0.2 mL (devices)

Parametri

1-5 mL/min flow rate
75 psi max. pressure

Dimensione pori

0.4 μm pore size

Raccordi

female inlet and outlet (luer)

applicazioni

pharmaceutical

Tecnica di separazione

strong anion exchange

Temperatura di conservazione

2-30°C

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Descrizione generale

Device Configuration: Flat-Sheet Capsule
The Natrix® Q Micro (0.2ml) is a scaled down, laboratory model for screening purposes, to fine tune buffer conditions, and assess load parameters before moving to small scale or commercial manufacturing.

Applicazioni

Chromatography

Azioni biochim/fisiol

Purification of biomolecules via anion exchange chromatography

Caratteristiche e vantaggi

The revolutionary marcroporous polymer of Natrix® Q chromatography membrane contains a high density of quaternary amine binding sites enabling rapid mass transfer, delivering high binding capacity even at fast flow rates. The combination of performance and speed in a single-use, plug-and-play device format enables low risk, scalable solutions for efficient biomolecule purification.

Confezionamento

Carton, 10/pack

Note legali

NATRIX is a registered trademark of Merck KGaA, Darmstadt, Germany

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

NXF-50

Natrix® Assorbitore a membrana Q

NXF-10

Natrix® Q Pilot

NXF-20

Natrix® Q Process 150

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Articoli

Chromatographic Purification of Plasmid DNA (pDNA) for mRNA, Plasmid-based DNA Vaccines, and Viral Vector Applications

See case study examples of how to optimize chromatographic purification of plasmid DNA for Biopharmaceutical Applications.

Egg-based and Cell-based Influenza Vaccine Manufacturing Methods

Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.

Cost Modeling Vaccine Manufacturing: Estimate Production Costs for mRNA and other Vaccine Modalities

A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.

Developing and Manufacturing Attenuated Viral Vaccines

Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.

Vedi tutto

Contenuto correlato

Adenovirus Vaccine Manufacturing Process

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.

Polishing Chromatography

Learn more on mAb downstream processing, more specifically polishing chromatography and the relevant associated products.

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.